Azacitidine favorably modulates PSA kinetics correlating with plasma DNA LINE-1 hypomethylation in men with chemonaïve castration-resistant prostate cancer. [electronic resource]
Producer: 20120308Description: 682-9 p. digitalISSN:- 1873-2496
- Adenocarcinoma -- blood
- Aged
- Aged, 80 and over
- Androgen Antagonists -- therapeutic use
- Antimetabolites, Antineoplastic -- therapeutic use
- Azacitidine -- therapeutic use
- Castration
- DNA Methylation -- drug effects
- Disease-Free Survival
- Drug Resistance, Neoplasm -- drug effects
- Humans
- Kaplan-Meier Estimate
- Long Interspersed Nucleotide Elements -- genetics
- Male
- Middle Aged
- Prostate-Specific Antigen -- blood
- Prostatic Neoplasms -- blood
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.